Barrett's esophagus and colorectal polyps have several overlapping risk factors. Whereas several reports in Western countries have indicated a close relationship between Barrett's esophagus and colorectal polyps, the relationship between these two diseases remains unclear in Japan. This study was performed to determine whether the prevalence of Barrett's esophagus is related to that of colorectal polyps in Japanese patients.

Methods

The present retrospective chart review included 1582 Japanese patients who underwent both total colonoscopy and esophagogastroduodenoscopy from January 2010 to December 2016. The data on colorectal polyps and Barrett's esophagus were obtained from the endoscopic findings. The medical record of each patient was checked for age, sex, body mass index, smoking, alcohol drinking, use of acid suppression agents, and comorbidities including a history of diabetes, ischemic heart disease, gastroesophageal reflux disease, hiatal hernia, and Helicobacter pylori infection.

Results

Colorectal polyps were detected in 789 of the 1582 patients (49.9%). Barrett's esophagus was detected in 233 patients (14.7%), and most cases of Barrett's esophagus (n = 229) were classified as short-segment Barrett's esophagus. Colorectal polyps were more frequent in patients with than without Barrett's esophagus (odds ratio, 1.79; 95% confidence interval, 1.31–2.46; P < 0.001). In addition to Barrett's esophagus, the data indicated that old age, male sex, obesity, smoking, alcohol drinking, diabetes mellitus, and ischemic heart disease were independent risk factors for colorectal polyps.

Conclusions

The present study revealed the correlation between the prevalence of Barrett's esophagus and colorectal polyps in Japanese patients.

References

1Watanabe T, Muro K, Ajioka Y et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int. J. Clin. Oncol. 2018; 23: 1–34.
10.1007/s10147-017-1101-6
PubMed Web of Science® Google Scholar
2Matsuda T, Chiu HM, Sano Y, Fujii T, Ono A, Saito Y. Surveillance colonoscopy after endoscopic treatment for colorectal neoplasia: from the standpoint of the Asia-Pacific region. Dig. Endosc. 2016; 28: 342–347.
10.1111/den.12622
PubMed Web of Science® Google Scholar
3Hirai HW, Ching JYL, Wu JCY, Sung JJY, Chan FKL, Ng SC. Risk factors for advanced colorectal neoplasms in the proximal colon in 6218 subjects undergoing complete colonoscopy. J. Gastroenterol. Hepatol. 2018. https://doi.org/10.1111/jgh.14357 [Epub ahead of print].
Web of Science® Google Scholar
4Vieira AR, Abar L, Chan DSM et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR continuous update project. Ann. Oncol. 2017; 28: 1788–1802.
10.1093/annonc/mdx171
CAS PubMed Web of Science® Google Scholar
5Nunez C, Nair-Shalliker V, Egger S, Sitas F, Bauman A. Physical activity, obesity and sedentary behaviour and the risks of colon and rectal cancers in the 45 and up study. BMC Public Health 2018; 18: 325.
10.1186/s12889-018-5225-z
PubMed Web of Science® Google Scholar
6He X, Wu K, Ogino S, Giovannucci EL, Chan AT, Song M. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology 2018; 155: 355–373.
10.1053/j.gastro.2018.04.019
PubMed Web of Science® Google Scholar
7Thrift AP. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Curr. Opin. Gastroenterol. 2016; 32: 319–324.
10.1097/MOG.0000000000000274
Web of Science® Google Scholar
8Yachimski P. Modifiable risk factors for Barrett's esophagus and esophageal adenocarcinoma: still a shot in the dark. Clin. Gastroenterol. Hepatol. 2016; 14: 773–774.
10.1016/j.cgh.2016.01.004
PubMed Web of Science® Google Scholar
9Schneider JL, Corley DA. The troublesome epidemiology of Barrett's esophagus and esophageal adenocarcinoma. Gastrointest. Endosc. Clin. N. Am. 2017; 27: 353–364.
10.1016/j.giec.2017.03.002
PubMed Google Scholar
10Tanaka Y, Sakata Y, Hara M et al. Risk factors for Helicobacter pylori infection and endoscopic reflux esophagitis in healthy young Japanese volunteers. Intern. Med. 2017; 56: 2979–2983.
10.2169/internalmedicine.8669-16
PubMed Web of Science® Google Scholar
11Erőss B, Farkas N, Vincze Á et al. Helicobacter pylori infection reduces the risk of Barrett's esophagus: a meta-analysis and systematic review. Helicobacter 2018; 23: e12504.
10.1111/hel.12504
PubMed Web of Science® Google Scholar
12Yamamoto K, Shimoda R, Ogata S et al. Perforation and postoperative bleeding associated with endoscopic submucosal dissection in colorectal tumors: an analysis of 398 lesions treated in Saga, Japan. Intern. Med. 2018; 57: 2115–2122.
10.2169/internalmedicine.9186-17
PubMed Web of Science® Google Scholar
13Tan MC, Murrey-Ittmann J, Nguyen T, Ketwaroo GA, El-Serag HB, Thrift AP. Risk profiles for Barrett's esophagus differ between new and prevalent, and long- and short-segment cases. PLoS One. 2016; 11.
10.1371/journal.pone.0169250
Web of Science® Google Scholar
14Sonnenberg A, Genta RM. Barrett's metaplasia and colonic neoplasms: a significant association in a 203,534-subjectstudy. Dig. Dis. Sci. 2013; 58: 2046–2051.
10.1007/s10620-013-2565-5
CAS Web of Science® Google Scholar
15Amano Y, Azumi T, Tsuboi M, Motoori S, Ishimura N. Epidemiology of Barrett's cancer in Japan: presents and perspective. Nihon Shokakibyo Gakkai Zasshi. 2015; 112: 219–231 (in Japanese).
PubMed Google Scholar
16Hatta W, Tong D, Lee YY, Ichihara S, Uedo N, Gotoda T. Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries. Dig. Endosc. 2017; 29: 18–25.
10.1111/den.12808
PubMed Web of Science® Google Scholar
17Oryu M, Mori H, Kobara H et al. Differences in the characteristics of Barrett's esophagus and Barrett's adenocarcinoma between the United States and Japan. ISRN Gastroenterol. 2013; 2013: 840690.
10.1155/2013/840690
Google Scholar
18Matsueda K, Manabe N, Toshikuni N et al. Clinical characteristics and associated factors of Japanese subjects with adenocarcinoma of the esophagogastric junction: a multicenter clinicoepidemiological study. Dis. Esophagus 2017; 30: 1–6.
10.1093/dote/dox007
CAS Web of Science® Google Scholar
19Sugimoto H, Kawai T, Naito S et al. Surveillance of short-segment Barrett's esophagus using ultrathin transnasal endoscopy. J. Gastroenterol. Hepatol. 2015; 30: 41–45.
10.1111/jgh.12879
PubMed Web of Science® Google Scholar
20Sugisaki N, Iwakiri R, Tsuruoka N et al. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients. J. Gastroenterol. 2018; 53: 1253–1260.
10.1007/s00535-018-1483-x
CAS Web of Science® Google Scholar
21Iwakiri K, Kinoshita Y, Habu Y et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J. Gastroenterol. 2016; 51: 751–767.
10.1007/s00535-016-1227-8
PubMed Web of Science® Google Scholar
22Kawada K, Kawano T, Nakajima Y. Diagnosis of Barrett's esophagus and Barrett's esophageal cancer by endoscopy. Gastroenterol. Endosc. 2017; 59: 70–80.
Google Scholar
23Spechler SJ, Souza RF. Barrett's esophagus. N. Engl. J. Med. 2014; 371: 836–845.
10.1056/NEJMra1314704
CAS PubMed Web of Science® Google Scholar
24Ghaus S, Neumann H, Muhammad H, Tontini GE, Ishaq S. Diagnosis and surveillance of Barrett's esophagus: addressing the transatlantic divide. Dig. Dis. Sci. 2016; 61: 2185–2193.
10.1007/s10620-016-4138-x
Web of Science® Google Scholar
25Wang A, Mattek NC, Holub JL, Lieberman DA, Eisen GM. Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig. Dis. Sci. 2009; 54: 964–971.
10.1007/s10620-009-0742-3
PubMed Web of Science® Google Scholar
26Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol. Clin. North Am. 2015; 44: 203–231.
10.1016/j.gtc.2015.02.001
PubMed Web of Science® Google Scholar
27Sontag SJ, Schnell TG, Chejfec G et al. Barrett's oesophagus and colonic tumours. Lancet 1985; 1: 946–949.
10.1016/S0140-6736(85)91725-8
CAS PubMed Web of Science® Google Scholar
28Robertson DA, Ayres RC, Smith CL. Screening for colonic cancer in subjects with Barrett's oesophagus. BMJ 1989; 298: 650.
10.1136/bmj.298.6674.650
CAS PubMed Web of Science® Google Scholar
29Siersema PD, Yu S, Sahbaie P et al. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest. Endosc. 2006; 63: 581–586.
10.1016/j.gie.2005.08.043
PubMed Web of Science® Google Scholar
30Bollschweiler E, Schloesser T, Leers J, Vallböhmer D, Schäfer H, Hölscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis. Colon Rectum 2009; 52: 299–304.
10.1007/DCR.0b013e318197d06f
PubMed Web of Science® Google Scholar
31de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in subjects with Barrett's esophagus: a Dutch population-based study. Am. J. Gastroenterol. 2010; 105: 77–83.
10.1038/ajg.2009.503
PubMed Web of Science® Google Scholar
32Kumaravel A, Thota PN, Lee HJ et al. Higher prevalence of colon polyps in subjects with Barrett's esophagus: a case-control study. Gastroenterol. Rep. 2014; 2: 281–287.
10.1093/gastro/gou050
Google Scholar
33Andrici J, Tio M, Cox MR, Eslick GD. Meta-analysis: Barrett's oesophagus and the risk of colonic tumours. Aliment. Pharmacol. Ther. 2013; 37: 401–410.
10.1111/apt.12146
CAS PubMed Web of Science® Google Scholar
34Cauvin JM, Goldfain D, Lerhun M et al. Multicentre prospective controlled study of Barrett's esophagus and colorectal adenomas. Lancet 1995; 346: 1391–1394.
10.1016/S0140-6736(95)92406-X
CAS PubMed Web of Science® Google Scholar
35Laitakari R, Laippala P, Isolauri J. Barrett's oesophagus is not a risk factor for colonic neoplasia: a case–control study. Ann. Med. 1995; 27: 499–502.
10.3109/07853899709002459
CAS PubMed Web of Science® Google Scholar
36Hamade N, Vennelaganti S, Parasa S et al. Lower annual rate of progression of short-segment vs long-segment Barrett's esophagus to esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 2018 https://doi.org/10.1016/j.cgh.2018.07.008 [Epub ahead of print].
10.1016/j.cgh.2018.07.008
Web of Science® Google Scholar
37Ocvirk S, O'Keefe SJ. Influence of bile acids on colorectal cancer risk: potential mechanisms mediated by diet–gut microbiota interactions. Curr. Nutr. Rep. 2017; 6: 315–322.
10.1007/s13668-017-0219-5
CAS PubMed Google Scholar
38Prichard DO, Byrne AM, Murphy JO et al. Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking. J. Cell. Mol. Med. 2017; 21: 3612–3625.
10.1111/jcmm.13271
CAS PubMed Web of Science® Google Scholar
39Souza RF. From reflux esophagitis to esophageal adenocarcinoma. Dig. Dis. 2016; 34: 483–490.
10.1159/000445225
PubMed Web of Science® Google Scholar
40Lee Y, Urbanska AM, Hayakawa Y et al. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus. Oncotarget 2017; 8: 203–214.
10.18632/oncotarget.10667
PubMed Google Scholar
41Han YM, Park JM, Kangwan N et al. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin. J. Physiol. Pharmacol. 2015; 66: 159–167.
CAS PubMed Web of Science® Google Scholar
42Wang JS, Guo M, Montgomery EA et al. DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus. Am. J. Gastroenterol. 2009; 104: 2153–2160.
10.1038/ajg.2009.300
CAS PubMed Web of Science® Google Scholar
43Nieto T, Tomlinson CL, Dretzke J et al. A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open 2018; 8: e020427.
10.1136/bmjopen-2017-020427
PubMed Web of Science® Google Scholar
44Taddei A, Fabbroni V, Pini A et al. Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus. Dig. Dis. Sci. 2014; 59: 949–957.
10.1007/s10620-013-2975-4
CAS Web of Science® Google Scholar
45Tsuruoka N, Iwakiri R, Sakata Y et al. Questionnaire-based survey on gastrointestinal bleeding and management of antithrombotic agents during endoscopy among Asian countries. Digestion 2018; 97: 97–106.
10.1159/000484228
Web of Science® Google Scholar
46Takasaki Y, Nagata N, Imbe K et al. Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: a long-term cohort study. United. Eur. Gastroenterol. J. 2017; 5: 1030–1036.
10.1177/2050640617693524
CAS Web of Science® Google Scholar
47Mohammed A, Yarla NS, Madka V, Rao CV. Clinically relevant anti-inflammatory agents for chemoprevention of colorectal cancer: new perspectives. Int. J. Mol. Sci. 2018; 19: 2332.
10.3390/ijms19082332
Web of Science® Google Scholar
48Bresalier RS. Chemoprevention of Barrett's esophagus and esophageal adenocarcinoma. Dig. Dis. Sci. 2018; 63: 2155–2162.
10.1007/s10620-018-5149-6
CAS Web of Science® Google Scholar
49Matsuura S, Sakata Y, Tsuruoka N et al. Outcomes of subjects undergoing endoscopic hemostasis for the upper gastrointestinal bleeding were not influenced by the timing of hospital emergency visits: a situation prevailing in Japan. Digestion 2018; 97: 260–266.
10.1159/000485653
Web of Science® Google Scholar
50Takeshita E, Sakata Y, Hara M et al. Higher frequency of reflux symptoms and acid-related dyspepsia in women than men regardless of endoscopic esophagitis: analysis of 3,505 Japanese subjects undergoing medical health checkups. Digestion 2016; 93: 266–271.
10.1159/000445713
PubMed Web of Science® Google Scholar

Citing Literature

Volume34, Issue7

July 2019

Pages 1160-1165

Correlation of Barrett's esophagus with colorectal polyps in Japanese patients: A retrospective chart review

Abstract

Background and Aim

Methods

Results

Conclusions

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Correlation of Barrett's esophagus with colorectal polyps in Japanese patients: A retrospective chart review

Abstract

Background and Aim

Methods

Results

Conclusions

References

Citing Literature

References

Related

Information